Human papillomavirus type 16 E5 protein

Papillomavirus Report

Volumn 15, Issue 1, 2004, Pages 1-6

  Bravo, Ignacio G ^a   Alonso, Angel ^a   Auvinen, Eeva ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

E5 protein; Human papillomavirus

Indexed keywords

GROWTH FACTOR; ONCOPROTEIN; PROTEIN E5; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

APOPTOSIS; CARCINOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHROMOSOME; DNA INTEGRATION; EPITHELIUM CELL; GENE DELETION; GENE FUNCTION; IMMUNOMODULATION; MITOGENICITY; NONHUMAN; ONCOGENE; PAPILLOMA VIRUS; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; WART VIRUS;

BOVINAE; BOVINE PAPILLOMAVIRUS; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 2342585533     PISSN: 09574190     EISSN: None     Source Type: Journal    
DOI: 10.1179/095741904225004233     Document Type: Review

References (59)

1. Seedorf K, Krämmer G, Dürst M, Suhai S, Röwekamp WG. Human papillomavirus type 16 DNA sequence. Virology 1985;145:181-5.
2. Bubb V, McCance DJ, Schlegel R. DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein. Virology 1988;163:243-6.
3. Burkhardt A, Willingham M, Gay C, Jenag KT, Schlegel R. The E5 oncoprotein of the bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology 1989;170:334-9.
4. Alonso A, Reed J. Modelling of the human papillomavirus type 16 E5 protein. Biochim Biophys Acta 2003;1601:9-18.
5. Yang DH, Wildeman AG, Sharom FJ. Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16. Prot Express Purific 2003;30:1-10.
6. Schlegel R, Wade-Glass M. E5 transforming polypeptide of bovine papillomavirus. Cancer Cells 1987;5:87-91.
7. Disbrow GL, Sunitha I, Baker CC, Hanover J, Schlegel R. Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology 2003;311:105-14.
8. Gieswein CE, Sharom FJ, Wildeman AG. Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. Virology 2003;313:415-26.
9. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-4.
10. Luft F, Klaes R, Nees M, Dürst M, Heilmann V, Melsheimer P et al. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cell. Int J Cancer 2001;92:9-17.
11. Stoler MH, Broker TR. In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol 1986;17:1250-8.
12. Dürst M, Glitz D, Schneider A, zur Hausen H. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 1992;189:132-140.
13. Koefoed Johnsen C, Stanley M, Norrild B. Analysis of human papillomavirus type 16 E5 oncogene expression in vitro and from bicistronic messenger RNAs. Intervirology 1995;38:339-45.
14. Eriksson A, Herron JR, Yamada T, Wheeler CM. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J Gen Virol 1999;80:595-600.
15. Bible JM, Mant C, Best JM, Kell B, Starkey WG, Raju KS et al. Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. J Gen Virol 2000;81:1517-27.
16. Leechanachai P, Banks L, Moreau F, Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 1992;7:19-25.
17. Pim D, Collins M, Banks L. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 1992;7:27-32.
18. Straight SW, Hinkle PM, Jewers RJ, McCance DJ. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 1993;67:4521-32.
19. Leptak C, Ramon Y, Cajal S, Kulke R, Horwitz BH, Riese II DJ et al. Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. J Virol 1991;65:7078-83.
20. Conrad Stöppler M, Straight SW, Tsao G, Schlegel R, McCance DJ. The E5 gene of HPV-16 enhances keratinocyte immortalization by full length DNA. Virology 1996;223:251-4.
21. Bouvard V, Matlashewski G, Gu ZM, Storey A, Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology 1994;203:73-80.
22. Faulkner Valle G, Banks L. The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. J Gen Virol 1995;76:1239-45.
23. Sparkowski J, Anders J, Schlegel R. E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells. EMBO J 1995;14:3055-63.
24. Oetke C, Auvinen E, Pawlita M, Alonso A. Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation. Arch Virol 2000;145:2183-91.
25. Chen SL, Mounts P. Detection by antibody probes of human papillomavirus type 16 E5 proteins in respiratory papillomata. J Med Virol 1989;29:273-83.
26. Kell B, Jewers RJ, Cason J, Pakarian F, Kaye JN, Best JM. Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides. J Gen Virol 1994;75:2451-6.
27. Chang JL, Tsao YP, Liu DW, Huang SJ, Lee WH, Chen SL. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J Biomed Sci 2001;8:206-13.
28. Crusius K, Auvinen E, Steuer B, Gaissert H, Alonso A. The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. Exp Cell Res 1998;241:76-83.
29. Gu Z, Matlashweski G. Effect of human papillomavirus type 16 oncogenes on MAP kinase activity. J Virol 1995;69:8051-6.
30. Crusius K, Auvinen E, Alonso A. Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene 1997;15:1437-44.
31. Conrad M, Goldstein D, Andresson T, Schlegel R. The ES protein of HPV-1, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology 1994;200:796-800.
32. Hwang ES, Nottoli T, DiMaio D. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 1995;211:227-33.
33. Conrad M, Bubb VJ, Schlegel R. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol 1993;67:6170-8.
34. Rodriguez MI, Finbow ME, Alonso A. Binding of the human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation. Oncogene 2000;19:3727-32.
35. +-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems. Virology 2000;272:315-25.
36. +-ATPase. J Gen Virol 2001;82:2353-62.
37. Straight SW, Herman B, McCance DJ. The E5 oncoprotein of human papillomavirus type 16 inhibits acidification of endosomes in human keratinocytes. J Virol 1995;69:3185-92.
38. Crusius K, Rodriguez I, Alonso A. The human papillomavirus type 16 E5 protein modulates erk1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes. Virus Genes 2000;20:65-9.
39. Thomsen P, van Deurs B, Norrild B, Kayser L. The HPV 16 E5 oncogene inhibits endocytic trafficking. Oncogene 2000;19:6023-32.
40. Oelze I, Kartenbeck J, Crusius K, Alonso A. Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J Virol 1995;69:4489-94.
41. King TJ, Fukushima LH, Hieber AD, Shimabukurol KA, Sakr WA, Bertram JS. Reduced levels of connexin 43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression. Carcinogenesis 2000;21:1097-109.
42. Ashrafi GH, Pitts JD, Faccini AM, McLean P, O'Brien V, Finbow ME et al. Binding of bovine papillomavirus type 4 E8 to ductin (16K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events. J Gen Virol 2000;81: 689-94.
43. Kabsch K, Alonso A. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J Virol 2002;76:12162-72.
44. Zhang B, Spandau DF, Roman A. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis. J Virol 2002;76:220-31.
45. Kabsch K, Alonso A. The human papillomavirus type 16 (HPV16) E5 protein sensitizes human keratinocytes to apoptosis induced by osmotic stress. Oncogene 2002;21:947-53.
46. Auvinen E, Alonso A, Auvinen P. Human papillomavirus type 16 E5 protein colocalizes with the antiapoptotic Bcl-2 protein. Arch Virol 2004; In press.
47. Burnett S, Jareborg N, DiMaio D. Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fibropapilloma tissue. Proc Natl Acad Sci USA 1992;89:5665-9.
48. Mayer TJ, Meyers C. Temporal and spatial expression of the E5a protein during the differentiation-dependent life cycle of human papillomavirus type 31b. Virology 1998;248:208-17.
49. Crum CP, Symbula M, Ward BE. Topography of early HPV16 transcription in high-grade genital precancers. Am J Pathol 1989;134:1183-8.
50. Fehrmann F, Klumpp DJ, Laimins LA. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol 2003;77:2819-31.
51. Genther SM, Sterling S, Duensing S, Münger K, Sattler C, Lambert PF. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J Virol 2003;77:2832-42.
52. Flores ER, Allen-Hoffmann BL, Lee D, Lambert PF. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J Virol 2000;74:6622-31.
53. Gill DK, Bible JM, Biswas C, Kell B, Best JM, Punchard NA et al. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high grade neoplasia. J Gen Virol 1998;79:1971-6.
54. Liu DW, Tsao YP, Hsieh CH, Hsieh JT, Kung JT, Chiang CL et al. Induction of CD8 cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth. J Virol 2000;74:9083-9.
55. Ashrafi GH, Tsirimonaki E, Marchetti B, O'Brien PM, Sibbet GJ, Andrew L et al. Down-regulation of MHC class I by bovine papillomavirus E5 oncoprotein. Oncogene 2002;21:248-59.
56. Marchetti B, Ashrafi GH, Tsirimonaki E, O'Brien PM, Campo MS. The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface. Oncogene 2002;21:7808-16.
57. Campo MS. Animal models of papillomavirus pathogenesis. Virus Res 2002;89:249-61.
58. Cartin W, Alonso A. The human papillomavirus HPV2a E5 protein localized to the Golgi apparatus and modulates signal transduction. Virology 2003;314:572-9.
59. Zhang B, Li P, Wang E, Brahmi Z, Dunn KW, Blum JS et al. The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-γ. Virology 2003;310:100-8.